Duceppe E, Borges FK, Tiboni M, Pearse R, Chan MTV, Srinathan S, Kavsak PA, Garg AX, Sessler DI, Sapsford R, Heels-Ansdell D, Pettit S, Vasquez J, Mueller C, Walsh M, Szczeklik W, Rodseth R, Lalu M, Thabane L, Guyatt G, Devereaux PJ: High-sensitivity cardiac troponin I thresholds to identify myocardial injury after noncardiac surgery: A cohort study. Can J Cardiol 2023; 39: 311-318- Outcomes Research Consortium

What we have done

OR in the News (selected articles)

<2023

Duceppe E, Borges FK, Tiboni M, Pearse R, Chan MTV, Srinathan S, Kavsak PA, Garg AX, Sessler DI, Sapsford R, Heels-Ansdell D, Pettit S, Vasquez J, Mueller C, Walsh M, Szczeklik W, Rodseth R, Lalu M, Thabane L, Guyatt G, Devereaux PJ: High-sensitivity cardiac troponin I thresholds to identify myocardial injury after noncardiac surgery: A cohort study. Can J Cardiol 2023; 39: 311-318

July 27, 2023

Background:
Myocardial injury after noncardiac surgery (MINS) is common and associated with short- and long-term major cardiovas- cular events. Diagnostic criteria for MINS using Abbott high-sensitivity cardiac troponin I (hs-cTnI) are unknown.
Methods:
We performed a prospective cohort study of adults who had in-patient noncardiac surgery and measured hs-cTnI (Abbott Labora- tories) on postoperative serum samples collected up to postoperative day 3. The objective was to determine prognostically important hs-cTnI thresholds associated with major cardiac events and death at 30 days after noncardiac surgery. Using Cox proportional iterative analyses, we determined peak postoperative hs-cTnI thresholds associated with the occurrence of the 30-day composite of major cardiac events (ie, nonfatal myocardial infarction after 3 postoperative days, cardiac ar- rest, and congestive heart failure) and death.
Results:
Of 3953 included patients, 66 (1.7%) experienced the pri- mary outcome at 30 days. Peak hs-cTnI values and associated inci- dence of major cardiac events and death were as follows: < 60 ng/L: 1.0% (95% CI 0.7-1.3); 60 to < 700 ng/L: 8.6% (5.6-13.0); and 700 ng/L: 27.3% (16.4-41.9). Compared with peak hs-cTnI < 60 ng/L, adjusted hazard ratios were 7.54 (95% CI% 4.27-13.32) for hs-cTnI values of 60 to < 700 ng/L and 26.87 (13.27-54.41) for values 700 ng/L. Conclusions:
Hs-cTnI elevation within the first 3 days after noncardiac surgery independently predicts major cardiac events and death at 30 days. A postoperative hs-cTnI 60 ng/L was associated with a > 7- fold increase in the risk of subsequent major cardiac events and mortality at 30 days.